3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Iduronidase: new trials by email Literature Review of Iduronidase trials Research Report on Iduronidase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Tolerance Study With Aldurazyme® (Laronidase) Laronidase, Cyclosporine A (CsA), Azathioprine (Aza) - Mucopolysaccharidosis I | Phase 1 / Phase 2 | Completed | Genzyme, a Sanofi Company | 7 | 2008-09-01 | 2014-07-02 |
| Stem Cell Transplant w/Laronidase for Hurler Stem Cell Transplant, Laronidase ERT - Mucopolysaccharidosis I, Hurler Syndrome | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 25 | 2004-03-01 | 2019-07-11 |
| A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old Aldurazyme (Recombinant Human Alpha-L-Iduronidase) - Mucopolysaccharidosis I, Hurler Syndrome | Phase 2 | Completed | Genzyme, a Sanofi Company | 20 | 2002-10-01 | 2015-04-03 |
Mucopolysaccharidosis I (3) · Metabolism, Inborn Errors (1) · Mucopolysaccharidoses (1)
Genzyme, a Sanofi Company (2) · Masonic Cancer Center, University of Minnesota (1)
Brazil (1) · France (1) · Germany (1) · Netherlands (1) · Russia (1) · United Kingdom (1) · United States (1)
Paul Orchard, MD (1)